Lilly Eli Co stock is traded at $1,431.67, with a volume of 3,067,109. It is down -0.82% in the last 24 hours and up +13.89% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,443.50
Open:
$1,453.75
24h Volume:
3,067,109
Relative Volume:
0.97
Market Cap:
$1.28T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.53
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+1.40%
1M Performance:
+13.89%
6M Performance:
+42.47%
1Y Performance:
+39.64%
1-Day Range:
$1,427.66$1,475.25
1-Week Range:
$1,400.00$1,475.25
52-Week Range:
$850.51$1,475.25
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS